Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousTreatment OutcomeBlood Transfusion, AutologousTransplantation ConditioningBone Marrow TransplantationGraft vs Host DiseaseStem Cell TransplantationCombined Modality TherapyHematologic NeoplasmsMelphalanPeripheral Blood Stem Cell TransplantationMultiple MyelomaCyclophosphamideT-LymphocytesWhole-Body IrradiationRemission InductionRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinRecurrenceBone Marrow PurgingMyeloablative AgonistsBusulfanCytotoxicity, ImmunologicT-Lymphocytes, CytotoxicLymphocyte ActivationCarmustineLymphocyte Culture Test, MixedTime FactorsSalvage TherapyDisease-Free SurvivalLeukemiaHodgkin DiseaseSurvival AnalysisHematopoietic Stem Cell MobilizationFollow-Up StudiesImmunotherapy, AdoptiveAntigens, NeoplasmEtoposideLeukemia, Myeloid, AcuteImmunotherapyGraft SurvivalAntigens, CD34Survival RateCytarabineHematologic DiseasesCancer VaccinesThiotepaTissue DonorsDendritic CellsCells, CulturedHLA AntigensHematopoietic Stem CellsHistocompatibility TestingCell TransplantationBone TransplantationHistocompatibilityGraft vs Leukemia EffectMelanomaPlatelet-Rich PlasmaFlow CytometryPlatelet TransfusionGraft vs Tumor EffectProspective StudiesAcute DiseaseLymphomaKiller Cells, NaturalAntibodies, MonoclonalChimerismNeoplasmsInterleukin-2AutograftsVidarabineHepatic Veno-Occlusive DiseaseTransplantation ChimeraCD4-Positive T-LymphocytesFeasibility Studies